Rate My Professor Laura Appleton

Appleton's academic work focuses on paediatric gastroenterology, particularly paediatric inflammatory bowel disease such as Crohn's disease and ulcerative colitis. Her contributions examine non-invasive biomarkers for monitoring disease activity, including fecal myeloperoxidase and calprotectin levels, serum oncostatin M as a predictor of mucosal healing, and the associations between granulomata presence and disease phenotypes or outcomes. She has also explored vitamin D therapy efficacy, point prevalence of paediatric IBD in New Zealand, age-dependent biomarker variations in cystic fibrosis and IBD patients, and dietary interventions like exclusive enteral nutrition. Key publications include 'Fecal Myeloperoxidase Levels Reflect Disease Activity in Children With Inflammatory Bowel Disease' (Inflammatory Bowel Diseases, 2024), 'Children With Cystic Fibrosis Have Elevated Levels of Fecal Myeloperoxidase' (Journal of Cystic Fibrosis, 2022), 'Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab' (Alimentary Pharmacology & Therapeutics, 2020), 'Associations between the Presence of Granulomata and Disease Phenotype and Outcomes in Children Diagnosed with Crohn's Disease' (Gastrointestinal Disorders, 2020), 'Vitamin D therapy in children with inflammatory bowel disease: A systematic review' (World Journal of Gastroenterology and Hepatology, 2019), 'Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand' (Inflammatory Intestinal Diseases, 2017), and 'Re: A Meta-Analysis of the Clinical Use of Curcumin for Irritable Bowel Syndrome' (Journal of Clinical Medicine, 2019). Appleton holds a BSc qualification.